• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

TAKENAKA Motoki  竹中 基記

ORCIDConnect your ORCID iD *help
… Alternative Names

竹中 基記  タケナカ モトキ

Less
Researcher Number 20566484
Other IDs
Affiliation (Current) 2025: 岐阜大学, 医学部附属病院, 医員
Affiliation (based on the past Project Information) *help 2018 – 2020: 岐阜大学, 医学部附属病院, 助教
Review Section/Research Field
Except Principal Investigator
Basic Section 56040:Obstetrics and gynecology-related
Keywords
Except Principal Investigator
活性酸素 / エラスチン / RAS変異 / 細胞死 / 鉄依存性 / 卵巣がん / 二価鉄 / フェリチン / オートファジー / フェロトーシス / フェントン反応 / 卵巣癌
  • Research Projects

    (1 results)
  • Research Products

    (13 results)
  • Co-Researchers

    (7 People)
  •  Treatment strategy of ovariam cancer, targeting the new programed all dezth, "Ferroptosis".

    • Principal Investigator
      Morishige Ken-ichirou
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Gifu University

All 2020 2019 2018

All Journal Article Presentation

  • [Journal Article] Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study.2020

    • Author(s)
      Iihara H, Shimokawa M, Hayasaki Y, Fujita Y, Abe M,Takenaka M, Yamamoto S, Arai T, Sakurai M, Mori M, Nakamura K, Kado N, Murase S, Shimaoka R, Suzuki A, Morishige KI
    • Journal Title

      Gynecol Oncol

      Volume: 156 Issue: 3 Pages: 629-635

    • DOI

      10.1016/j.ygyno.2020.01.004

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Journal Article] MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor2020

    • Author(s)
      Kawaguchi Masaya、Kato Hiroki、Hatano Yuichiro、Tomita Hiroyuki、Hara Akira、Suzui Natsuko、Miyazaki Tatsuhiko、Furui Tatsuro、Morishige Ken-ichirou、Matsuo Masayuki
    • Journal Title

      Japanese Journal of Radiology

      Volume: 38 Issue: 8 Pages: 782-789

    • DOI

      10.1007/s11604-020-00960-2

    • NAID

      50014569067

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18H02765, KAKENHI-PROJECT-18K09257
  • [Presentation] プラチナ感受性再発卵巣癌におけるオラパリブ維持療法の有効性と安全性の検討.2020

    • Author(s)
      青島友維、早崎容、坊本佳優、村瀬紗姫、竹中基記、森重健一郎
    • Organizer
      第72回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] 卵巣癌におけるフェロトーシス誘導剤アルテスネートの効果の検討.2020

    • Author(s)
      小池大我、竹中基記、鈴木紀子、森美奈子、上田陽子、平山祐、永澤秀子、森重健一郎
    • Organizer
      日本酸化ストレス学会東海支部第8回学術集会
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] 岐阜大学産婦人科におけるBRCA遺伝子変異症例について2019

    • Author(s)
      村瀬紗姫、坊本佳優、竹中基記、早崎容、森重健一郎
    • Organizer
      第57回日本癌治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] 進行卵巣癌の初回治療におけるBevacizumabの有効性についての検討2019

    • Author(s)
      桒原万友香、竹中基記、村瀬紗姫、早崎容、桑山太郎、神田智子、横山康宏、山田新尚、森重健一郎
    • Organizer
      第57回日本癌治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] 進行卵巣癌におけるオラパリブ維持療法の評価について2019

    • Author(s)
      坊本佳優、竹中基記、桒原万友香、村瀬紗姫、上田陽子、早崎容、古井辰郎、森重健一郎
    • Organizer
      第57回日本癌治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] 進行卵巣癌における、Bevacizumab導入前後の臨床プロフィールの比較・検討2019

    • Author(s)
      桒原万友香、早崎容、溝口冬馬、村瀬紗姫、竹中基記、森重健一郎
    • Organizer
      第71回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] RAS dependent programed cell death termed ”Ferroptosis” in ovarian cancer2018

    • Author(s)
      Takenaka M, Suzuki N, Mori M, Koike T, Aoki H, Hirayama T, Nagasawa H, Morishige K-I
    • Organizer
      the 17th Biennial Meeting of the International Gynecologic Cancer Society(IGCS 2018)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] 新規プログラム細胞死「フェロトーシス」の卵巣癌での位置づけ2018

    • Author(s)
      竹中基記、鈴木紀子、青木仁美、森美奈子、小池大我、上田陽子、平山 祐、永澤秀子、森重健一郎
    • Organizer
      第39回癌免疫外科研究会
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] RAS変異卵巣癌におけるフェロトーシス誘導薬エラスチンの有用性2018

    • Author(s)
      竹中基記、鈴木紀子、青木仁美、森美奈子、小池大我、上田陽子、平山祐、永澤秀子、森重健一郎
    • Organizer
      第6回婦人科がんバイオマーカー研究会学術集会
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] Ferroptosis induced by erastinin RAS mutant ovarian cancer cells2018

    • Author(s)
      Takenaka M, Suzuki N, Mori M, Koike T, Aoki H, Hirayama T, Nagasawa H, Morishige K-I
    • Organizer
      American Association for Cancer Research (AACR) Annual Meeting 2018
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K09257
  • [Presentation] Ferroptosis induced by erastin in RAS mutant ovarian cancer cells2018

    • Author(s)
      Takenaka M, Mori M, Ueda Y, Kikuno K, Morishige K
    • Organizer
      第70回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-18K09257
  • 1.  Morishige Ken-ichirou (90283788)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 12 results
  • 2.  上田 陽子 (20795075)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 5 results
  • 3.  鈴木 紀子 (40642096)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 6 results
  • 4.  森 美奈子 (60585610)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 8 results
  • 5.  MATSUO Masayuki
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 6.  森 崇
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 7.  富田 弘之
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi